Intravenous Iron Drugs Market Share

Statistics for the 2023 & 2024 Intravenous Iron Drugs market share, created by Mordor Intelligence™ Industry Reports. Intravenous Iron Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research Injectables Research Intravenous Injections Research Intravenous Iron Drugs Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Intravenous Iron Drugs Industry

The intravenous iron drugs market is consolidated and consists of a few players across the globe. In terms of market share, a few of the major players are currently dominating the market. Some of the companies that hold a significant market share are CSL Limited (Vifor Pharma Management Ltd.), AbbVie (Allergan), Covis Pharma GmbH (AMAG Pharmaceuticals, Inc), Sanofi, Pharmocos, Shield Therapeutics Rockwell Medical, American Regent among others.

Intravenous Iron Drugs Market Leaders

  1. Sanofi

  2. Pharmocosmos

  3. AbbVie (Allergan)

  4. Covis Pharma GmbH (AMAG Pharmaceuticals, Inc)

  5. CSL Limited (Vifor Pharma Management Ltd.)

*Disclaimer: Major Players sorted in no particular order

Picture3.png

Intravenous Iron Drugs Market Report Snapshots

Intravenous Iron Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)